Trend Analysis Report: Agilent Technologies Inc (NYSE:A), Ryanair Holdings plc (ADR) (NASDAQ:RYAAY)
Trading the news is a technique to trade equities, currencies and other financial instruments on the financial markets. Trading news releases can be a noteworthy tool for financial shareholders. Economic news reports often drive strong short-term moves in the markets, which may create trading opportunities for traders. Declarations about corporate profits, a change in administration, rumors of a merger, are events that can cause a company’s share price to move wildly up or down. Interest rates, unemployment and export rates, or the central bank’s policy shifts, can cause a deep change of an exchange rate.
Shares of Agilent Technologies Inc (NYSE:A) gained 0.23% to $61.50 on Monday, after a global leader in life sciences, diagnostics and applied chemical markets, declared that it has attained the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population Genetics”). Founded in 2005, Population Genetics was formed to commercialize the intellectual property portfolio of Nobel Laureate Sydney Brenner focused on high sensitivity and high specificity Next Generation Sequencing (“NGS”) detection. In 2015, Population Genetics became an IP holding entity with over 30 patents. Financial terms of the purchase were not revealed.
The stock floated in a price range of $61.25 to $61.58. The stock moved on low volume, traded at a volume of 973,808 shares, as compared to its average daily volume of 1.78 million shares. The market capitalization for the company is reported at $19.89 Billion.
“Our customers are increasingly requiring fully integrated next-generation sequencing workflows with the highest performance,” said Herman Verrelst, vice president and general manager of Agilent’s Genomics Division. “With the addition of this IP portfolio, we can now deliver complete target enrichment solutions to our customers that they can trust, from QC to target enrichment, to analysis and interpretation that meets this demand.”
The attained Population Genetics IP includes patents related to both molecular and sample barcoding that improve accuracy and sensitivity of NGS detection. The combination of these patents provides for customizable target enrichment solutions that enable customers to detect ultra-low mutation frequencies in very small DNA quantities. These features are ideal for detection of rare-variants in cancer and reproductive genetics, counting liquid biopsies.
“We are excited to bring these technologies to our customers,” said Jacob Thaysen, president of Agilent’s Diagnostics and Genomics Group. “We outlined a strategy to grow in the diagnostics space, and to build a complete routine clinical NGS workflow. This acquisition is another example of executing on that strategy, and our commitment to assisting our customers improves the quality of life.”
Agilent’s newest next generation sequencing library prep solution, Agilent SureSelectXT HS, incorporates molecular barcodes from this IP portfolio. The incorporation of these molecular barcodes improves the overall precision and produces higher complexity libraries than competing products, on a broad range of tissue types and low- and high-quality FFPE samples.
Agilent and Population Genetics had a previous licensing arrangement providing Agilent with licensing rights to certain Population Genetics molecular barcode patented technology, which allows for the sensitive and confident detection of minority genetic variants on next generation sequencing platforms to levels below 0.1%.
Ryanair Holdings plc (ADR) (NASDAQ:RYAAY) declined -0.97 points or -0.86% at the market, after a holding company for Ryanair Limited (Ryanair), stated fiscal first-quarter profit of $436.7 million. On a per-share basis, the Dublin-based company said it had profit of $1.78. The airline posted revenue of $2.1 billion in the period.
The stock opened at $109.90. It reached an intraday trading high of $111.66 and closed at $111.50. The total volume traded for the day is 1.02 million, as compared to its average daily volume of 258,702 shares. The current EPS for the company has been recorded at $6.07 and the beta value recorded by the company stands at 0.56 points.